Why is "Nature Medicine" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-06-17 09:41:35
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Nature_Medicine entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-06-17 and was most recently seen on 2026-06-17.
Wikipedia Overview
Nature Medicine is a monthly peer-reviewed medical journal published by Nature Portfolio covering all aspects of medicine. It was established in 1995. The journal seeks to publish research papers that "demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results". Nature Medicine also publishes reviews, perspectives and other content commissioned from leading scientists in their fields. As with other Nature journals, there is no external editorial board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. The editor-in-chief is João Monteiro.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Short-term effects of combinations of heart failure therapies on blood pressure, kidney function and serum potassium - Nature
-
Lessons from deploying the ChatEHR system at Stanford Medicine - Nature
-
Obesity medicines as disruptive innovation - Nature
-
Recombinant shingles vaccination and the risk of cardiovascular events - Nature
-
Dysregulated adult hippocampal neurogenesis in major depressive disorder - Nature
-
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer - Nature
-
Overcrowded Ebola treatment centers are fueling transmission in the Democratic Republic of the Congo - Nature
-
Atezolizumab in early triple-negative breast cancer: the randomized phase 3 NSABP B-59/GeparDouze trial - Nature
-
How to build an AI-driven digital organism - Nature
-
Generalizable AI predicts immunotherapy outcomes across cancers and treatments - Nature
-
The genetic architecture of fibromyalgia across 2.5 million individuals - Nature
-
Induced pluripotent stem cells from discovery to translation - Nature
-
Blood-based circular RNAs for early diagnosis of Alzheimer’s disease - Nature
-
Individualized antisense oligonucleotides for SCN2A- related developmental epileptic encephalopathy - Nature
-
Health system learning enables generalist neuroimaging models - Nature
-
Longitudinal plasma proteomics predict phenoconversion to clinically manifest ALS - Nature
-
Immune aging biomarkers for clinical trials - Nature
-
Sleep as therapy - Nature
-
Plasma proteomic signatures of cellular aging predict human disease - Nature
-
Electronic cigarette use after smoking cessation and lung cancer risk - Nature
-
General-purpose large language models outperform specialized clinical AI tools on medical benchmarks - Nature
-
Physical activity for public health in the 21st century - Nature
-
A neuroprosthesis for restoring hand movement and sensation in a person with complete tetraplegia - Nature
-
AI framework for multidisease detection via retinal imaging - Nature
-
ChatGPT Health performance in a structured test of triage recommendations - Nature
-
An agentic framework for autonomous scientific discovery in cancer pathology - Nature
-
Reliability of LLMs as medical assistants for the general public: a randomized preregistered study - Nature
-
Nature Medicine Commission on dialysis policy in low- and middle-income countries - Nature
-
Human microglial transitions at the Aβ–tau inflection point associate with divergent pathways to dementia and resilience - Nature
-
Biological aging clocks in health and disease - Nature
-
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling - Nature
-
A multimodal sleep foundation model for disease prediction - Nature
-
Rice faculty co-lead Nature Medicine commission to advance brain capital as a driver of economic resilience - Rice University
-
The next generation of antibody–drug conjugates - Nature
-
Shared and specific blood biomarkers for multimorbidity - Nature
-
Advancing conversational diagnostic AI with multimodal reasoning - Nature
-
Who owns my health data? - Nature
-
Antibiotic use and gut microbiome composition links from individual-level prescription data of 14,979 individuals - Nature
-
Plasma proteomic signature of the human menstrual cycle - Nature
-
Nature Medicine’s June 2026 Benchmark Study Reveals General-Purpose LLMs Outperform FDA-Cleared Clinical AI — and Exposes a Validation Gap Regulators Have Not Closed - The Clinical Trial Vanguard
-
Low-plastic diet and urinary levels of plastic-associated phthalates and bisphenols: the randomized controlled PERTH Trial - Nature
-
A clinical environment simulator for dynamic AI evaluation - Nature
-
Enhanced dynamic risk stratification of smoldering multiple myeloma - Nature
-
A large language model for complex cardiology care - Nature
-
The new vision from the National Institute of Allergy and Infectious Diseases (NIAID) - Nature
-
Global and regional cancer burden attributable to modifiable risk factors to inform prevention - Nature
-
The AI co-scientist is here - Nature
-
The global macroeconomic burden of diabetes mellitus - Nature
-
Eleven clinical trials that will shape medicine in 2026 - Nature
-
A cognitive layer architecture to support large-language model performance in psychotherapy interactions - Nature
-
Single-cell atlas of the developing Down syndrome brain cortex - Nature
-
Interpretable inflammation landscape of circulating immune cells - Nature
-
Climate change and infectious diseases - Nature
-
Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation - Applied Clinical Trials Online
-
Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing - Fierce Pharma
-
Citywide premarital genomic screening in a Middle Eastern population - Nature
-
The All of Us Research Program’s wearables dataset - Nature
-
The science of psychedelic medicine - Nature
-
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m. - The Cancer Letter
-
An LLM chatbot to facilitate primary-to-specialist care transitions: a randomized controlled trial - Nature
-
Nature Medicine’s 2026 Medical AI Superintelligence Framework Signals What FDA Benchmarking Guidance Has Not Yet Addressed - The Clinical Trial Vanguard
-
Microbial signals in primary and metastatic brain tumors - Nature
-
A multimodal whole-slide foundation model for pathology - Nature
-
CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial - Nature
-
The expanding landscape of GLP-1 medicines - Nature
-
Nature Medicine Retracts NSCLC Immunochemotherapy Trial: 6 Serious Concerns Explained - Oncodaily
-
Macrovascular tumor infiltration and circulating tumor cell cluster dynamics in patients with cancer approaching the end of life - Nature
-
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications - Yahoo Finance
-
Circular Genomics Unveils Its CircPATH™ Platform Following Landmark Nature Medicine Study Demonstrating Breakthrough Performance in Early Detection of Alzheimer's Disease - PR Newswire
-
Determining the value of genomics in healthcare - Nature
-
Characterizing the physiology of circulatory arrest in humans - Nature
-
Ractigen Therapeutics Announces Landmark Publication in Nature Medicine Highlighting Unprecedented Preclinical Efficacy and Positive First-in-Human Clinical Data for RAG-17 in SOD1-ALS - PR Newswire
-
Muna Therapeutics Announces Nature Medicine Publication Validating Microglial State Transitions as Key Drivers of Alzheimer's - BioSpace
-
Daily multivitamin may slow biological aging - Harvard Gazette
-
ImmunoBrain Announces Nature Medicine Publication and Late-Breaking AAIC 2026 Presentation for IBC-Ab002 in Early Alzheimer's Disease - PR Newswire
-
Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity - Yahoo Finance
-
Generative artificial intelligence in medicine - Nature
-
Varicella-zoster virus reactivation and the risk of dementia - Nature
-
Feinstein Institutes Technology That Restores Movement and Sensation After Paralysis Featured in Nature Medicine - Business Wire
-
Queen Mary to coordinate new Nature Medicine global obesity data Commission - Queen Mary University of London
-
A consensus blood transcriptomic framework for sepsis - Nature
-
Dietary profiles and associated metabolic risk factors in India from the ICMR–INDIAB survey-21 - Nature
-
Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy - Biogen
-
Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research - PR Newswire
-
Paolo Tarantino: Nature Medicine Retracts Debated Study on Early Morning Immunotherapy Benefits - Oncodaily
-
Neuvotion Announces Commercialization of Brain-Computer Interface and Brain-Body Interface Technologies – Related Clinical Study Published in Nature Medicine - Morningstar
-
455 charged in $6.5 billion health care fraud takedown; judge blocks rule limiting loans for nursing and PA students; Nature Medicine retracts cancer-timing study — Morning Medical Update Weekly Recap - Medical Economics
-
Actuate Therapeutics Announces Nature Medicine Publication of Clinical Trial Results Showing Doubling of the Rate of Survival with Elraglusib Plus Chemotherapy in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma - GlobeNewswire
-
Joao Monteiro: Nature Medicine Offers Fast-Track Publication for Late-Breaking Clinical Trials - Oncodaily
-
Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity - Barchart.com
-
Kiora's Phase 1 ABACUS Study of KIO-301 in Retinitis Pigmentosa Published in Nature Medicine; Phase 2 Trial Underway - TMX Newsfile
-
Impressive Benefits and an Excellent Safety and Tolerability Profiles in Two Severely Affected Patients With Mutations in a Vital Sodium Channel (SCN2A) Treated With Bespoke ASOs Reported in Nature Medicine - Business Wire
-
August AI Correctly Identifies Every Emergency Case in Evaluation Against Nature Medicine Safety Benchmark - PR Newswire
-
Building the world’s first truly global medical foundation model - Nature
-
Alto Neuroscience Highlights Nature Medicine Publication Demonstrating Significant Effects of Pramipexole on Anhedonia - Business Wire
-
Nature Medicine Study: Daily multivitamin may slow biological aging - Drug Store News
-
Inflammatix Announces Three Landmark Publications in Nature Medicine that Redefine Acute Infection and Sepsis Diagnosis and Treatment - PR Newswire
-
Double neural bypass technology restores movement and sensation in paralyzed patient - KNOE
-
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at - GlobeNewswire
-
AskBio Announces Publication in Nature Medicine of 12-month data from Phase 1 Trial of AB-1002 Gene Therapy in Participants with Congestive Heart Failure - Bayer
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.